{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:11:32Z","timestamp":1777525892606,"version":"3.51.4"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Digit. Health"],"abstract":"<jats:sec><jats:title>Hypothesis<\/jats:title><jats:p>The main hypothesis is that a digital, biodata-driven, and personalized program would exhibit high user retention and engagement, followed by more effective management of their depressive and anxiety symptoms.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>This pilot study explores the feasibility, acceptability, engagement, and potential impact on depressive and anxiety and quality of life outcomes of the 16-week Feel Program. Additionally, it examines potential correlations between engagement and impact on mental health outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This single-arm study included 48 adult participants with mild or moderate depressive or anxiety symptoms who joined the 16-week Feel Program, a remote biodata-driven mental health support program created by Feel Therapeutics. The program uses a combination of evidence-based approaches and psychophysiological data. Candidates completed an online demographics and eligibility survey before enrolment. Depressive and anxiety symptoms were measured using the Patient Health Questionnaire and Generalized Anxiety Disorder Scale, respectively. The Satisfaction with Life Scale and the Life Satisfaction Questionnaire were used to assess quality of life. User feedback surveys were employed to evaluate user experience and acceptability.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total, 31 participants completed the program with an overall retention rate of 65%. Completed participants spent 60 min in the app, completed 13 Mental Health Actions, including 5 Mental Health Exercises and 4.9 emotion logs on a weekly basis. On average, 96% of the completed participants were active and 76.8% of them were engaged with the sensor during the week. Sixty five percent of participants reported very or extremely high satisfaction, while 4 out of 5 were very likely to recommend the program to someone. Additionally, 93.5% of participants presented a decrease in at least one of the depressive or anxiety symptoms, with 51.6 and 45% of participants showing clinically significant improvement, respectively. Finally, our findings suggest increased symptom improvement for participants with higher engagement throughout the program.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The findings suggest that the Feel Program may be feasible, acceptable, and valuable for adults with mild or moderate depressive and\/or anxiety symptoms. However, controlled trials with bigger sample size, inclusion of a control group, and more diverse participant profiles are required in order to provide further evidence of clinical efficacy.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fdgth.2022.868970","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T06:27:57Z","timestamp":1658471277000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Feasibility, engagement, and preliminary clinical outcomes of a digital biodata-driven intervention for anxiety and depression"],"prefix":"10.3389","volume":"4","author":[{"given":"Charalampos","family":"Tsirmpas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Andrikopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis","family":"Fatouros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Eleftheriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaquin A.","family":"Anguera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Kontoangelos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charalabos","family":"Papageorgiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,22]]},"reference":[{"key":"B1","unstructured":"Understand Anxiety and Depression: Facts and Statistics2022"},{"key":"B2","article-title":"Promoting mental health in Europe: Why and how?","volume-title":"Health at a Glance: Europe 2018: State of Health in the EU Cycle","year":"2018"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e729","DOI":"10.1016\/S2468-2667(21)00047-5","article-title":"Prevalence and variability of current depressive disorder in 27 European countries: a population-based study","volume":"60","author":"Jorge","year":"2021","journal-title":"Lancet Public Health"},{"key":"B4","unstructured":"Depression in Europe: Facts and Figures2022"},{"key":"B5","doi-asserted-by":"crossref","unstructured":"Disability-Adjusted Life Years (DALYs)2013","DOI":"10.1289\/isee.2013.O-2-18-03"},{"key":"B6","unstructured":"Depression and Other Common Mental Disorders: Global Health Estimates2017"},{"key":"B7","article-title":"Assessment and conclusions - The OECD mental health and work policy framework","volume-title":"FitMind, Fit Job: From Evidence to Practice inMental Health and Work","year":"2015"},{"key":"B8","unstructured":"Fitter Minds, Fitter Jobs2021"},{"key":"B9","unstructured":"Mental Health and Substance Use2022"},{"key":"B10","unstructured":"Mental Health and Work2021"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1017\/S0033291717002781","article-title":"Trends in depression prevalence in the USA from 2005 to 2015: widening disparities in vulnerable groups","volume":"48","author":"Weinberger","year":"2018","journal-title":"Psychol Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e20161878","DOI":"10.1542\/peds.2016-1878","article-title":"National trends in the prevalence and treatment of depression in adolescents and young adults","volume":"138","author":"Mojtabai","year":"2016","journal-title":"Pediatrics"},{"key":"B13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.tem.2021.10.005","article-title":"The menace of obesity to depression and anxiety prevalence","volume":"48","author":"Fulton","year":"2021","journal-title":"Trends Endocrinol Metab"},{"key":"B14","unstructured":"Adult Psychiatric Morbidity Survey: Survey of Mental Health and Wellbeing2022"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.15585\/mmwr.mm7040e3","article-title":"National and state trends in anxiety and depression severity scores among adults during the COVID-19 Pandemic \u2013 United States, 2020\u20132021","volume":"70","author":"Jia","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jpsychires.2021.11.037","article-title":"Trends of depression and anxiety during massive civil unrest and COVID-19 in Hong Kong, 2019\u20132020","volume":"145","author":"Hou","year":"2022","journal-title":"J Psychiatr Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"P1700","DOI":"10.1016\/S0140-6736(21)02143-7","article-title":"Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic","volume":"398","author":"Santomauro","year":"2021","journal-title":"Lancet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1017\/S0033291717003336","article-title":"Socio-economic variations in the mental health treatment gap for people with anxiety, mood, and substance use disorders: results from the WHO World Mental Health (WMH) surveys","volume":"48","author":"Evans-Lacko","year":"2018","journal-title":"Psychol Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1176\/appi.ps.201800094","article-title":"Predicting barriers to treatment for depression in a U","volume":"69","author":"Chekroud","year":"2018","journal-title":"Psychiatr Serv"},{"key":"B20","unstructured":"Depression: Fact sheets2022"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1001\/jama.291.21.2581","article-title":"Prevalence, severity, and unmet need for treatment of mental disorders in the world health organization world mental health surveys","volume":"291","year":"2004","journal-title":"JAMA"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.11604\/pamj.2013.14.159.1970","article-title":"Barriers to mental health services utilization in the Niger Delta region of Nigeria: service users perspectives","volume":"14","author":"Izibeloko J","year":"2013","journal-title":"Pan Afr Med J"},{"key":"B23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12913-016-1280-2","article-title":"Barriers to mental health service utilisation in Sudan - perspectives of carers and psychiatrists","volume":"16","author":"Ali","year":"2015","journal-title":"BMC Health Serv Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/wps.20231","article-title":"Toward a new definition of mental health","volume":"14","author":"Galderisi","year":"2015","journal-title":"World Psychiatry"},{"key":"B25","volume-title":"Exploring Barriers to the Utilization of Mental Health Services at the Policy and Facility Levels in Khartoum State, Sudan","author":"Abdelgadir","year":"2012"},{"key":"B26","unstructured":"Understand Anxiety and Depression: Treatment & Management2021"},{"key":"B27","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/sj.mp.4001852","article-title":"Treatment-resistant anxiety disorders","volume":"11","author":"Bystritsky","year":"2006","journal-title":"Mol Psychiatry"},{"key":"B28","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1017\/S2045796018000355","article-title":"Is psychotherapy effective? A re-analysis of treatments for depression","volume":"28","author":"Munder","year":"2019","journal-title":"Epidemiol Psychiatr Sci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"key":"B30","doi-asserted-by":"publisher","first-page":"242","DOI":"10.4274\/tjps.galenos.2020.49799","article-title":"Factors associated with antidepressant medication non-adherence","volume":"18","author":"Marasine","year":"2021","journal-title":"Turkish J Pharmaceut Sci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/YCO.0000000000000086","article-title":"Factors predicting adherence to antidepressant treatment","volume":"27","author":"Hung","year":"2014","journal-title":"Curr Opin Psychiatry"},{"key":"B32","doi-asserted-by":"publisher","first-page":"827","DOI":"10.4088\/JCP.09m05528blu","article-title":"Reasons for antidepressant nonadherence among veterans treated in primary care clinics","volume":"72","author":"Fortney","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"B33","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/ajh.2011.256","article-title":"Symptoms of depression and anxiety and adherence to antihypertensive medication","volume":"25","author":"Bautista","year":"2012","journal-title":"Am J Hypertens"},{"key":"B34","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2147\/PPA.S29716","article-title":"Treatment-resistant depression: therapeutic trends, challenges, and future directions","volume":"6","author":"Al-Harbi","year":"2012","journal-title":"Patient Prefer Adherence"},{"key":"B35","unstructured":"Demand for Virtual Mental Health Care Is Soaring. Here Are Key Trends on Who Is Using it Why2022"},{"key":"B36","unstructured":"Digital Behavioral Health Startups Scored $588M in Funding Amid COVID-19 Pandemic2022"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.2196\/jmir.2248","article-title":"A service-based evaluation of a therapist-supported online cognitive behavioral therapy program for depression","volume":"15","author":"Sharry","year":"2013","journal-title":"J Med Internet Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.cpr.2012.02.004","article-title":"Computer-based psychological treatments for depression: a systematic review and meta-analysis","volume":"32","author":"Derek","year":"2012","journal-title":"Clin Psychol Rev"},{"key":"B39","doi-asserted-by":"publisher","first-page":"9690","DOI":"10.1016\/S0140-6736(09)61257-5","article-title":"Therapist-delivered internet psychotherapy for depression in primary care: a randomised controlled trial","volume":"374","author":"David","year":"2009","journal-title":"Lancet"},{"key":"B40","doi-asserted-by":"publisher","first-page":"PCC.09r00876","DOI":"10.4088\/PCC.09r00876blu","article-title":"Use of the internet to assist in the treatment of depression and anxiety: a systematic review","volume":"12","author":"Wade","year":"2010","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"B41","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1192\/bjp.bp.108.054429","article-title":"Clinical effectiveness of online computerised cognitive-behavioural therapy without support for depression in primary care: randomised trial","volume":"195","author":"de Graaf","year":"2009","journal-title":"Br J Psychiatry"},{"key":"B42","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s00592-014-0598-7","article-title":"Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study","volume":"51","author":"Hommel","year":"2014","journal-title":"Acta Diabetol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s00592-021-01820-9","article-title":"Hybrid closed Loop improved glucose control compared to sensor-augmented pumps in outpatients with type 1 diabetes in real-life conditions with telehealth monitoring","volume":"59","author":"Thivolet","year":"2021","journal-title":"Acta Diabetol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"19976","DOI":"10.1001\/jama.2016.19976","article-title":"Continuous glucose monitoring vs. conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections: the GOLD randomized clinical trial","volume":"317","author":"Lind","year":"2017","journal-title":"JAMA"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.3390\/ijerph17041431","article-title":"Effectiveness and safety in remote monitoring of patients with pacemakers five years after an implant: the poniente study","volume":"17","author":"L\u00f3pez-Liria","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"B46","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1016\/j.ijcard.2013.01.253","article-title":"Long term quality-of-life in patients with bradycardia pacemaker implantation","volume":"168","author":"Udo","year":"2013","journal-title":"Int J Cardiol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/jclp.1056","article-title":"A survival analysis of clinically significant change in outpatient psychotherapy","volume":"57","author":"Anderson","year":"2001","journal-title":"J Clin Psychol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"9782","DOI":"10.2196\/mental.9782","article-title":"Using psychological artificial intelligence (tess) to relieve symptoms of depression and anxiety: randomized controlled trial","volume":"5","author":"Fulmer","year":"2018","journal-title":"JMIR Ment Health"},{"key":"B49","doi-asserted-by":"publisher","first-page":"75","DOI":"10.31234\/osf.io\/8wpq7","article-title":"Feasibility and efficacy of the addition of heart rate variability biofeedback to a remote digital health intervention for depression","volume":"45","author":"Economides","year":"2020","journal-title":"Appl Psychophysiol Biofeedback"},{"key":"B50","doi-asserted-by":"publisher","first-page":"100408","DOI":"10.1016\/j.invent.2021.100408","article-title":"Significant reduction in depressive symptoms among patients with moderately-severe to severe depressive symptoms after participation in a therapist-supported, evidence-based mobile health program delivered via a smartphone app","volume":"25","author":"Valerie","year":"2021","journal-title":"Internet Intervent"},{"key":"B51","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1089\/tmj.2016.0114","article-title":"A study of asynchronous mobile-enabled sms text psychotherapy","volume":"23","author":"Hull","year":"2017","journal-title":"Telemed e-Health"},{"key":"B52","first-page":"e141","article-title":"Leveraging remote behavioral health interventions to improve medical outcomes and reduce costs","volume":"21","author":"Reena","year":"2015","journal-title":"Am J Manag Care"},{"key":"B53","unstructured":"Our Impact in Virtual Therapy and Counseling2022"},{"key":"B54","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41746-020-0293-8","article-title":"A pragmatic randomized waitlist-controlled effectiveness and cost-effectiveness trial of digital interventions for depression and anxiety","volume":"3","author":"Richards","year":"2020","journal-title":"npj Digit Med"},{"key":"B55","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1037\/t12710-000","article-title":"Happiness and domain-specific life satisfaction in adult northern Swedes","volume":"5","author":"Fugl-Meyer","year":"1991","journal-title":"Clin Rehabil"},{"key":"B58","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1207\/s15327752jpa4901_13","article-title":"The satisfaction with life scale","volume":"49","author":"Diener","year":"1985","journal-title":"J Pers Assess"},{"key":"B59","unstructured":"EleftheriouG\n            FatourosP\n            TsirmpasC\n          METHOD FOR DETECTING RECOGNIZING AN EMOTIONAL STATE OF A USER.2020"},{"key":"B60","article-title":"International Conference on Harmonisation of Technical Requirements for Registration for Human Use (ICH)","year":"1998","journal-title":"Guidance for Industry: E9 Statistical Principle for Clinical Trials"},{"key":"B61","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/nep.13709","article-title":"Intention to treat and per protocol analysis in clinical trials","volume":"25","author":"Tripepi","year":"2020","journal-title":"Nephrology"},{"key":"B62","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1503\/cmaj.112004","article-title":"Enhancing the clinical utility of depression screening","volume":"184","author":"Kroenke","year":"2012","journal-title":"CMAJ"},{"key":"B63","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jad.2020.01.032","article-title":"Sensitivity to change and minimal clinically important difference of the 7-item generalized anxiety disorder questionnaire (GAD-7)","volume":"265","author":"Toussaint","year":"2020","journal-title":"J Affect Disord"},{"key":"B64","unstructured":"Scikit-learn: machine learning in python282530\n            PedregosaF\n            VaroquauxG\n            GramfortA\n            MichelV\n            ThirionB\n            GriselO\n          J Mach Learn Res122011"},{"key":"B65","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1377\/hlthaff.2013.0133","article-title":"Access and cost barriers to mental health care, by insurance status, 1999\u20132010","volume":"32","author":"Rowan","year":"2013","journal-title":"Health Aff"},{"key":"B66","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1037\/0022-006X.51.3.390","article-title":"Stages and processes of self-change of smoking: toward an integrative model of change","volume":"51","author":"Prochaska","year":"1983","journal-title":"J Consult Clin Psychol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1037\/0022-006X.62.3.522","article-title":"Effects of treatment duration and severity of depression on the effectiveness of cognitive-behavioral and psychodynamic-interpersonal psychotherapy","volume":"62","author":"Shapiro","year":"1994","journal-title":"J Consult Clin Psychol"}],"container-title":["Frontiers in Digital Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdgth.2022.868970\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T13:57:01Z","timestamp":1658757421000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fdgth.2022.868970\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,22]]},"references-count":67,"alternative-id":["10.3389\/fdgth.2022.868970"],"URL":"https:\/\/doi.org\/10.3389\/fdgth.2022.868970","relation":{},"ISSN":["2673-253X"],"issn-type":[{"value":"2673-253X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,22]]},"article-number":"868970"}}